HealthEconomics.Com

Connected. Community.

  • facebook
  • linkedin
  • twitter
  • vimeo
  • rss
  • Will Improving Adherence Optimize Medication Use?
  • News
  • Jobs
    • HE Jobs Portal
    • View all Jobs
    • Post a Job
  • The HEOR & RWE Marketplace
    • Visit the Market Place
    • On-demand Webinar
  • Industry Events
    • 5 Tips for Trade Show Success
    • HE Innovation Webinar
    • Webinar Services from HealthEconomics.Com
    • View Conferences
    • View Webinars
    • View Webinar Archives
  • Newsletters
    • Subscribe
    • View All
  • Blog
  • Resources
    • Value Communication
    • Free Marketing Consultation!
    • The Future of Print Medical Journals: How to Stay Relevant
    • Be a Better Writer
    • White Papers
    • Education Resources
    • Syndicated Reports
    • Books
    • Databases
    • Blogs
      • HE-Artists
      • Podcasts
  • HE Institute
You are here: Home / Archives for Featured

Panalgo’s IHD Platform to Be Used by the EU Medicines Agency for Real-World Data Analytics

Panalgo, a leading healthcare analytics company, today announced that its Instant Health Data (IHD) platform will be used by the European Medicines Agency (EMA) to facilitate the analysis of real-world data. EMA will use IHD to undertake rapid analyses of Electronic Healthcare Data (EHDs) […]

more info 01/06/2021View Related Articles
Bookmark and Share

Tracing the Health Care Experience Informs Decision-making

Mapping the patient journey is a worthwhile exercise to undertake because it answers critical questions of interest to all health care stakeholders. The richness of patient journey mapping can help develop patient cohorts and assess effectiveness of therapeutics. Total health care utilization and […]

more info 01/06/2021View Related Articles
Bookmark and Share

Why Population Health Isn’t the ‘Virtuous’ Approach

Mark Ganz isn't a fan of healthcare's fixation on population health. Ganz, who recently left the role of CEO of Cambia Health Solutions, told Fierce Healthcare in a recent interview that looking at health through a population lens creates distance between the healthcare system and the patient […]

more info 01/06/2021View Related Articles
Bookmark and Share

Driving More Value and Cost Savings With SDOH Data

Getting a Social Determinant of Health (SDOH) initiative off the ground requires thoughtful coordination and analysis between analytics teams, clinicians, social workers and others, and buy-in from leadership. SDOH data includes details about income, education, race, gender and other social factors. […]

more info 01/06/2021View Related Articles
Bookmark and Share

ICER Seeks Applications for New Health Technology Assessment Fellowship

The Institute for Clinical and Economic Review (ICER) is now accepting applications for the inaugural cycle of a new Health Technology Assessment (HTA) Fellowship. The ICER HTA Fellowship is a paid full-time one-year program for post-master's and post-doctoral graduates that provides experiential […]

more info 01/05/2021View Related Articles
Bookmark and Share

RxSense Joins with Hy-Vee to Launch New PBM Vivid Clear Rx

RxSense was founded in 2015 with a singular focus on developing technology solutions that improve healthcare transparency and access to more affordable medications. RxSense also utilizes its advanced platform and direct contracts with the nation’s largest pharmacies (including CVS, Walmart and […]

more info 01/05/2021View Related Articles
Bookmark and Share

Healthcare Venture Launched by Amazon, JPMorgan and Berkshire Hathaway Goes Bust

Haven—the healthcare company formed by Amazon, JPMorgan Chase and Berkshire Hathaway—is apparently no more. The healthcare company began telling employees on Monday about plans to shut down by the end of next month, CNBC reported first on Monday morning. Haven was first announced in January 2018 as […]

more info 01/05/2021View Related Articles
Bookmark and Share

Hospitals Lose Another Attempt to Stave Off Price Transparency

A federal appeals court ruled against hospitals' efforts to stop regulators from forcing them to reveal the secret negotiated prices they reach with insurers, according to an opinion filed Tuesday. Hospitals were hoping for intervention from the D.C. Circuit Court of Appeals as the rule requires […]

more info 01/05/2021View Related Articles
Bookmark and Share

How Does Cost-Sharing Impact Spending Growth and Cost-Effective Treatments?

The growth of health care spending has been a longstanding policy concern. Over the years, several innovations have been proposed to lower levels of health care spending; however, their impact has been limited and not sustained over time. Costly new technology, while often an improvement to existing […]

more info 01/05/2021View Related Articles
Bookmark and Share

Impact of the Pandemic on Medical and Scientific Affairs

In the latest episode of Impetus Digital's Fireside Chat, Dr. Shurjeel Choudhri, SVP and Head, Medical and Scientific Affairs, Bayer Canada, joins me for a wide-ranging conversation on several hot topics in Pharma and healthcare. Among many other things, we explore innovative digital technologies, […]

more info 01/05/2021View Related Articles
Bookmark and Share

The Medical Science Liaison-DISC Personality Types Survey

The MSL role is constantly evolving and facing new challenges. MSLs are both scientific experts and relationship managers. As such, they are required to perform tasks that are extremely analytical and technical in nature, while being able to skilfully handle relationships on a human level. Each of […]

more info 01/04/2021View Related Articles
Bookmark and Share

Trends That Matter for COVID Vaccine Distribution

As details continue to emerge about the availability of COVID-19 vaccines and how they will be administered, the role that payers will play in the process is becoming clearer, AIS Health reported. It's imperative for health plans to do two key things at the same time, according to Katherine […]

more info 01/04/2021View Related Articles
Bookmark and Share

Drug Wholesale Prices Impact Payer Spending, Out-of-pocket Costs

Increases in drug wholesale list prices have a trickle-down effect that negatively impacts patient financial responsibility, such as out-of-pocket costs, and payer spending, according to a study published in JAMA Network Open. In recent years, the pharmaceutical industry has been scrutinized for […]

more info 01/04/2021View Related Articles
Bookmark and Share

Use of Real-world Evidence in Economic Assessments of Pharmaceuticals in the US

In a recent study, investigators from the University of Washington School of Pharmacy reviewed cost-effectiveness and budget impact analyses in final evidence reports of pharmaceuticals published by ICER, calculating total number of RWE uses and the proportion of model inputs informed by RWE per […]

more info 01/04/2021View Related Articles
Bookmark and Share

How Healthcare is Leveraging Real-World Data to Improve Outcomes

To improve outcomes during the COVID-19 pandemic and beyond, organizations are using real-world data for efficient and effective decision-making. At a time like this, researchers and leaders have to look beyond time-intensive, expensive randomized controlled trials. In order to find the answers to a […]

more info 01/04/2021View Related Articles
Bookmark and Share

Scientist.com Reflects on the Resounding Successes of 2020

As 2020 comes to a close, we'd like to thank you for supporting our mission here at Scientist.com. Whether you have recently joined the marketplace or have been a part of the network for years, we are honored to have you as part of a community dedicated to creating Faster Science. Looking back on […]

more info 01/04/2021View Related Articles
Bookmark and Share

Employee Health Data Analyses Must Include Race And Ethnicity

As the COVID-19 pandemic has highlighted, at the core of racial equity and social justice movements are health disparities along racial and ethnic lines. Health inequities can be addressed in the workplace through access to culturally sensitive programs and equitable health benefits for all […]

more info 12/28/2020View Related Articles
Bookmark and Share

[On-demand Conference] Real World Evidence: Meet the Future with Confidence

COVID-19 is impacting all of us and challenging previous ways of working. This is a period of disruption. In this new reality, RWE will take a more prominent role to improve patient outcomes, meet stakeholder needs, and answer business questions.  Join Pharmaceutical Executive®, IQVIA, and leading […]

more info 12/28/2020View Related Articles
Bookmark and Share

NICE Updates Methods for Health Technology Evaluations

On November 6, 2020, NICE published a summary of its proposed changes to health technology evaluation methods. NICE periodically assesses its methods to optimize the process and ensure it can support rapid access to clinically- and cost-effective technologies. Within the scope of this process, […]

more info 12/18/2020View Related Articles
Bookmark and Share

ICER Analytics™ Launched to Accelerate the Real-World Application of ICER Reports

Last month, saw the launch of ICER Analytics, a new cloud-based platform that will revolutionize the ability of payers, life science companies, patient groups, and others to develop formularies, negotiate drug prices, and explore new ways to apply evidence in a drive toward a health system that can […]

more info 12/18/2020View Related Articles
Bookmark and Share

eBook: The role of RWE in FDA approvals

As industry prepares for the FDA’s draft RWE guidance in 2021, Aetion conducted a systematic review of FDA approval documents in 2019 to understand what role RWE plays in informing regulatory decisions. This eBook will guide you through when, where, and how RWE studies have supported the approvals […]

more info 12/18/2020View Related Articles
Bookmark and Share

ICER Publishes Final Evidence Report for Bladder Cancer Therapies

The Institute for Clinical and Economic Review (ICER) today released a Final Evidence Report and Report-at-a-Glance assessing the comparative clinical effectiveness and value of nadofaragene firadenovec (Adstiladrin®, FKD Therapies Oy and FerGene) and oportuzumab monatox (Vicineum™, Sesen Bio) for […]

more info 12/18/2020View Related Articles
Bookmark and Share

PRECISIONxtract Increasing Life Sciences Commercialization Capabilities

PRECISIONxtract, a Precision Value & Health team, announced the launch of two new and innovative product lines, EHR Connect™ and Access Genius™. These best-in-class solutions enable life science clients to achieve new levels of HCP engagement through leveraging sophisticated strategies, enhanced […]

more info 12/16/2020View Related Articles
Bookmark and Share

Addressing the Affordability Crisis of Cell & Gene Therapies

In a recent Reuters Events poll, 43% of pharma said that reimbursement policy and legislation (e.g Best Price) is the most significant challenge in addressing market access issues related to cell and gene therapies. While there are indeed many common goals amongst pharma and healthcare when it comes […]

more info 12/16/2020View Related Articles
Bookmark and Share

GoodRx Adds Telehealth and Mail-delivery

GoodRx, announced this morning that it was adding telehealth and mail-delivery to its subscription savings program, called GoodRx Gold, giving members access to the same free medication delivery that Amazon now advertises for its Prime subscription members, plus discounts on telehealth visits. […]

more info 12/16/2020View Related Articles
Bookmark and Share

RxAdvance’s Sculley: What the PBM of the Future Might Look Like

The traditional models for pharmacy benefit managers have been under particular scrutiny of late, with these companies seeing the revival and finalization of the dreaded "rebate rule" and a Supreme Court ruling that could open the door for greater regulation. With these increasing calls for […]

more info 12/16/2020View Related Articles
Bookmark and Share

Identifying High-Risk COVID Patients Through Early Symptoms and Other Risk Factors

As cases of the coronavirus continue to rise in the US and globally, there is increasing need to find more efficient ways to identify at-risk populations and find potential solutions to protect people from symptom onset. In a recent study, Nancy A Dreyer, chief scientific officer and senior vice […]

more info 12/15/2020View Related Articles
Bookmark and Share

Digital Health Outcomes partners with the Institute for Clinical and Economic Review (ICER)

We are celebrating the launch of the next generation interactive modelling platform! Many thanks to our clients and partners, especially those who were the early adopters of our technology solutions for #healtheconomics ICER press release – https://lnkd.in/ewkzUTE Digital Health Outcomes home […]

more info 12/15/2020View Related Articles
Bookmark and Share

Scientist.com to Acquire HealthEconomics.Com, the World’s Leading Connected Community for Health Economics and Outcomes Research

Scientist.com, the healthcare industry’s leading marketplace for outsourced R&D, announced today it will acquire HealthEconomics.Com, a private US-based company that has spent the last 25 years creating a global Connected Community™ of scientists and suppliers of health economics and outcomes […]

more info 12/15/2020View Related Articles
Bookmark and Share

[Podcast] A Prescription for Fair Drug Pricing

ICER has announced the launch of a new podcast series entitled “A Prescription for Fair Drug Pricing.” In this series ICER’s President Dr. Steve Pearson sits with neurologist Dr. Jason Crowell as they try to better understand and unpack the financial and ethical tensions underpinning the US […]

more info 12/11/2020View Related Articles
Bookmark and Share

  • Previous Page
  • 1
  • 2
  • 3
  • 4
  • …
  • 116
  • Next Page

 

View All JobsPost a JobView Current NewsletterSubscribe to Newsletters
Conference of the Week:

Link of the Week:

Job of the Week:

Webinar of the Week:

White Papers

  • Payers: The New Catalysts of Better Health
  • A writer’s role in drug development: a guide to getting started in regulatory medical writing
  • Virtual Medical Conferences: The new normal?
  • How Healthy Are Your Market Access Programs? ​​​​​​​A guide to performing check-ups on pharmaceutical distribution and patient access programs
  • The Overlooked Patient: How payers can identify, engage and treat the vulnerable populations not participating in their own care
  • Unlocking the potential of a Chief Outcomes Officer
  • Pharma’s path for digital health solutions
  • Gartner 2020 Magic Quadrant for Data Science + Machine Learning Platforms
  • How Are Changing Reimbursement Models Affecting Denials?
  • Regulation and Market Climate Force the Issue of CDM Prices
  • The Missing C-Suite Role
  • Patient- or Participant-Generated Registries
  • Multinational Registries: Challenges and Opportunities
  • Managing Missing Data in Patient Registries
  • Biorepositories
  • Increasing Focus on the Patient in Patient Registries
  • DIA DIRECT: Real-World Data to Inform COVID-19 Response: Collaborating in the COVID-19 Evidence Accelerator
  • Demonstrating the Value of Drugs for Rare Diseases – 8 Common Challenges and How to Address Them Before They Arise
  • How to Put AI + Predictive Analytics To Work
  • Insurance Design and Pharmaceutical Innovation
  • Global Biosimilars Pathways and Clinical Development Activity
  • Telemedicine adoption grew in most EU5 markets as COVID mitigation measures took hold
  • Mitigating COVID-19-related healthcare disruption
  • Marketing during COVID-19: A guide for pharma solution providers
  • State of Patient Centricity 2020: Advancing from Patient-first Intentions to True Co-creation
  • Alternative Policies for Pricing Novel Vaccines and Drug Therapies for COVID-19
  • Bayesian Methodologies for COVID-19 Drugs, Devices and Biologics
  • Excellence In Payer Engagement: Strategic Outputs From A Roundtable Discussion
  • Evidence Generation and Communication: A Guide to Getting Started in HEOR/Market Access Medical Writing
  • Preparing for ICER assessments: key recommendations for manufacturers

Syndicated Reports

  • Pharmaceutical Payment System Market – Quantitative Analysis, Current and Future Trends, 2020 – 2027
  • The Future of Personalised Medicine: The Role of Simulation and Digital Twins
  • Medical Diagnostics: leveraging new opportunities from AI driven technology
  • Massive Growth in Digital Health Technology Market by Athenahealth, McKesson Corporation, Qualcomm, LifeWatch, AT & T, Cerner Corporation, Philips Healthcare, Cisco Systems
  • Real World Evidence: The Role of Medical Affairs
  • Pharmacy Benefit Management (PBM) – Industry Size 2019, Market Opportunities, Share Analysis up to 2025
  • Democrats and Drug Pricing
  • Global Health Economics & Outcomes Research (HEOR) Services Market Size, Share, Growth, Status and Forecast 2019-2025
  • Global Value-Based Reimbursement Software Market Size, Status and Forecast to 2026
  • Benchmarking Key Account Management Capabilities (2019)
  • The Future of Key Account Management in Pharma
  • Indication-level Pricing: Payer Insights
  • Real-World Data Capabilities: Benchmarking Pharma Companies (2019)
  • Success in Managed Markets: Payer Insights
  • Real World Data and Evidence: Payer Insights
  • KAM Metrics: Measuring Success (2019)
  • Biomarkers and Companion diagnostics: Payer Insights
  • Paying for Digital Health: Payer Insights (2019)
  • Biosimilars: U.S. Market Analysis, Insights and Forecast, 2019-2026
  • Biosimilars: US Payer Insights (2019)
  • Review of Influence: The Institute for Clinical and Economic Review
  • Innovative Drugs: Mapping the Pricing and Reimbursement Landscape
  • Orphan Drugs: European Payer Perspectives
  • Do Payers Really Want Pay-for-Performance?
  • Payer Engagement: Benchmarking Team Structure and Activity
  • Benchmarking Market Access Strategies for High-Cost Drugs and Biologics
  • Blockchain: Transformational Change for Pharma?
  • HTA in Europe: Key Success Factors for Positive HTA Recommendations
  • Paying for Digital Health: Payer Insights
  • Benchmarking Pharma’s MSL Capabilities
HealthEconomics.Com

HealthEconomics.Com

  • Become a Better Writer!
  • HealthEconomics.Com Recognized as Top Influencer at ISPOR International Meeting in Washington DC
  • Will ICER Framework Destroy Progress Against Multiple Myeloma?
  • Celgene Unleashes the Power of Data into Clinical Trial Design
  • How Well is Harvoni Working in the Real World?
  • New CVS and Express Scripts Value Based Plans for Oncology
  • Oversized Cancer Drug Vials Waste $3B Each Year
  • Can More Data Make Providers’ Jobs Easier?
  • News
  • Conferences
  • Reports
  • Jobs
  • Consulting
  • Newsletters
  • White Papers

More Links

  • Take This Survey for a Chance to Win $200!
  • Jobs
  • Education
  • Graduate Schools
  • Webinar Services

Support & Contact

  • ICER Releases Two Draft Reports on Obeticholic Acid
  • What do Patient Advocates Think of New ICER Report?
  • Could a New ICER Report Put Patients at Risk?
  • Contact Us

About

  • International Myeloma Foundation Responds to ICER Report
  • About Us
  • Advertise
  • Webinar Services
  • HE Institute
  • Testimonials
  • Privacy Policy

Stay Connected

  • facebook
  • twitter
  • linkedin
  • pinterest
  • google-plus
  • youtube
  • rss

HealthEconomics.Com is the world’s most comprehensive and credible CONNECTED COMMUNITYTM that serves as the global link to the health economics & outcomes research (HEOR) and pharma market access stakeholder communities.

HEALTHECONOMICS HZ SMALL V2

HE Institute

Strategy, Training, Education, and Communications in HEOR & Market Access.

Innovation Webinar

Big ideas accelerating change in HEOR, RWE and Health Technology. Learn more!

tHEORetically Speaking Blog

Insights and observations for HEOR, market access, pricing, reimbursement, and health policy.

HE Jobs Portal

Your Premier Employment Source for HEOR, Market Access, and Real World Evidence

HE Webinars

Online educational and informational seminars for HEOR, market access, pricing, and reimbursement.
  • Doctor Evidence Launches GROWTH Replicator Program
  • Is PCORI Underfunding CER?
  • HealthEconomics.Com
  • About HealthEconomics.Com
  • Advertising Inquiries
  • Careers
  • Contact HealthEconomics.Com

HealthEconomics.Com is the world’s most comprehensive and credible CONNECTED COMMUNITYTM that serves as the global link to the health economics & outcomes research (HEOR) and pharma market access stakeholder communities, proving news, education, jobs, resources, policy updates, consulting, advertising, all available via website, newsletters, and social media.

© 2017 Health Economics. All rights reserved.

  • Will Improving Adherence Optimize Medication Use?
  • News
  • Jobs
    • HE Jobs Portal
    • View all Jobs
    • Post a Job
  • The HEOR & RWE Marketplace
    • Visit the Market Place
    • On-demand Webinar
  • Industry Events
    • 5 Tips for Trade Show Success
    • HE Innovation Webinar
    • Webinar Services from HealthEconomics.Com
    • View Conferences
    • View Webinars
    • View Webinar Archives
  • Newsletters
    • Subscribe
    • View All
  • Blog
  • Resources
    • Value Communication
    • Free Marketing Consultation!
    • The Future of Print Medical Journals: How to Stay Relevant
    • Be a Better Writer
    • White Papers
    • Education Resources
    • Syndicated Reports
    • Books
    • Databases
    • Blogs
      • HE-Artists
      • Podcasts
  • HE Institute